The December 2013 edition of the transplant trial watch is now available on the CET site, as well as via our app for iPhone, iPad and Android.
This month trials include long-term follow-up of the BENEFIT study, hand assisted retroperitoneoscopic nephrectomy and steroid-free renal transplantation with Alemtuzumab induction.